A detailed history of Panagora Asset Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Panagora Asset Management Inc holds 63,120 shares of RPRX stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
63,120
Previous 63,120 -0.0%
Holding current value
$1.59 Million
Previous $1.66 Million 7.27%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$26.26 - $29.9 $3.4 Million - $3.87 Million
-129,378 Reduced 67.21%
63,120 $1.66 Million
Q1 2024

May 07, 2024

SELL
$27.46 - $31.33 $2.43 Million - $2.77 Million
-88,517 Reduced 31.5%
192,498 $5.85 Million
Q4 2023

Feb 08, 2024

BUY
$26.21 - $29.22 $5.64 Million - $6.29 Million
215,142 Added 326.6%
281,015 $7.89 Million
Q3 2023

Oct 31, 2023

BUY
$26.26 - $31.38 $433,946 - $518,554
16,525 Added 33.49%
65,873 $1.79 Million
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $582,585 - $700,453
17,778 Added 56.31%
49,348 $1.78 Million
Q4 2022

Feb 13, 2023

SELL
$39.17 - $44.04 $747,676 - $840,635
-19,088 Reduced 37.68%
31,570 $1.25 Million
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $2.65 Million - $2.96 Million
-66,325 Reduced 56.7%
50,658 $2.04 Million
Q2 2022

Aug 15, 2022

BUY
$37.53 - $44.22 $3.96 Million - $4.67 Million
105,620 Added 929.51%
116,983 $4.92 Million
Q3 2021

Nov 10, 2021

SELL
$36.14 - $42.24 $90,277 - $105,515
-2,498 Reduced 18.02%
11,363 $411,000
Q2 2021

Aug 11, 2021

SELL
$39.85 - $46.63 $65,632 - $76,799
-1,647 Reduced 10.62%
13,861 $568,000
Q1 2021

May 12, 2021

BUY
$42.34 - $52.82 $353,496 - $440,994
8,349 Added 116.62%
15,508 $676,000
Q4 2020

Feb 10, 2021

BUY
$36.12 - $50.05 $258,583 - $358,307
7,159 New
7,159 $358,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.